Allspring Global Investments Holdings LLC Sells 66,319 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Allspring Global Investments Holdings LLC reduced its stake in shares of Abrdn Life Sciences Investors (NYSE:HQL) by 19.1% during the third quarter, Holdings Channel reports. The institutional investor owned 280,302 shares of the company’s stock after selling 66,319 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Abrdn Life Sciences Investors were worth $4,227,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Cetera Advisors LLC purchased a new position in Abrdn Life Sciences Investors during the first quarter valued at approximately $1,929,000. Oppenheimer & Co. Inc. boosted its holdings in Abrdn Life Sciences Investors by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 18,414 shares of the company’s stock worth $251,000 after buying an additional 814 shares during the period. Sanctuary Advisors LLC bought a new position in Abrdn Life Sciences Investors in the 2nd quarter worth $154,000. B. Riley Wealth Advisors Inc. purchased a new stake in Abrdn Life Sciences Investors in the 1st quarter worth $143,000. Finally, Wedbush Securities Inc. raised its holdings in Abrdn Life Sciences Investors by 8.2% during the second quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock valued at $236,000 after acquiring an additional 1,261 shares during the period. 32.21% of the stock is currently owned by institutional investors.

Abrdn Life Sciences Investors Stock Up 0.3 %

NYSE HQL opened at $14.96 on Tuesday. Abrdn Life Sciences Investors has a twelve month low of $11.43 and a twelve month high of $15.90. The business has a 50-day moving average price of $15.13 and a 200-day moving average price of $14.48.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, August 23rd were issued a $0.49 dividend. The ex-dividend date was Friday, August 23rd. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48. This represents a $1.96 dividend on an annualized basis and a yield of 13.10%.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.